Juniper Pharmaceuticals, Inc. (JNP) Stock Analysis
DELISTED 2018
What happened to Juniper Pharmaceuticals, Inc. (JNP) stock?
Juniper Pharmaceuticals, Inc. (JNP) no longer trades on public markets. It was delisted in August 2018. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- August 2018
- Last recorded price (historical):
- $11.50 (last quote on record before the August 2018 delisting; historical, not a current quote)
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Juniper Pharmaceuticals, Inc. (JNP). Juniper Pharmaceuticals, Inc. (JNP) specializes in developing and manufacturing pharmaceutical products, with a core focus on women's health. The company's market position is centered around therapeutics and devices for contraception and hormone therapy.
Last analyzed: Jun 15, 2026Juniper Pharmaceuticals, Inc. (JNP) Healthcare & Pipeline Overview
More about this archive record
Can I still buy JNP shares?
No. JNP stopped trading on public markets in August 2018, so the shares are not available through a broker. Anything you see quoted for JNP elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before JNP stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Juniper Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.